Next Article in Journal
Applying a Chemogeographic Strategy for Natural Product Discovery from the Marine Cyanobacterium Moorena bouillonii
Previous Article in Journal
Hatsusamides A and B: Two New Metabolites Produced by the Deep-Sea-Derived Fungal Strain Penicillium steckii FKJ-0213
Previous Article in Special Issue
The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation

Marine Antithrombotics

Department of BioMolecular Sciences, Pharmacognosy Division, Research Institute of Pharmaceutical Sciences School of Pharmacy, University of Mississippi, Oxford, MS 38677-1848, USA
Author to whom correspondence should be addressed.
Mar. Drugs 2020, 18(10), 514;
Received: 29 August 2020 / Revised: 24 September 2020 / Accepted: 1 October 2020 / Published: 13 October 2020
(This article belongs to the Special Issue Marine Molecules for the Treatment of Thrombosis)
Thrombosis remains a prime reason of mortality worldwide. With the available antithrombotic drugs, bleeding remains the major downside of current treatments. This raises a clinical concern for all patients undergoing antithrombotic therapy. Novel antithrombotics from marine sources offer a promising therapeutic alternative to this pathology. However, for any potential new molecule to be introduced as a real alternative to existing drugs, the exhibition of comparable anticoagulant potential with minimal off-target effects must be achieved. The relevance of marine antithrombotics, particularly sulfated polysaccharides, is largely due to their unique mechanisms of action and lack of bleeding. There have been many investigations in the field and, in recent years, results have confirmed the role of potential marine molecules as alternative antithrombotics. Nonetheless, further clinical studies are required. This review covers the core of the data available so far regarding the science of marine molecules with potential medical applications to treat thrombosis. After a general discussion about the major biochemical steps involved in this pathology, we discuss the key structural and biomedical aspects of marine molecules of both low and high molecular weight endowed with antithrombotic/anticoagulant properties. View Full-Text
Keywords: alkaloids; anticoagulation; antithrombosis; fucosylated chondroitin sulfate; polyphenols; sulfated polysaccharides; terpenoids alkaloids; anticoagulation; antithrombosis; fucosylated chondroitin sulfate; polyphenols; sulfated polysaccharides; terpenoids
Show Figures

Figure 1

MDPI and ACS Style

Dwivedi, R.; Pomin, V.H. Marine Antithrombotics. Mar. Drugs 2020, 18, 514.

AMA Style

Dwivedi R, Pomin VH. Marine Antithrombotics. Marine Drugs. 2020; 18(10):514.

Chicago/Turabian Style

Dwivedi, Rohini, and Vitor H. Pomin. 2020. "Marine Antithrombotics" Marine Drugs 18, no. 10: 514.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop